ST. LOUIS--(BUSINESS WIRE)--GenoMed™ (Pink Sheets:GMED), the Next Generation Disease Management company whose business is public health™, announced today that its published approach to cancer has recently received support from a group at Thomas Jefferson University in Philadelphia.
